
Please try another search
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in Phase 2b/3 clinical trial to prevent esophageal varices in patient with non-alcoholic steatohepatitis cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. Galectin Therapeutics Inc. has a collaborative joint venture co-owned by SBH Sciences, Inc. with Galectin Sciences, LLC for the research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Name | Age | Since | Title |
---|---|---|---|
Kevin D. Freeman | 63 | 2011 | Independent Vice Chairman of the Board |
Gilbert S. Omenn | 83 | 2009 | Independent Director |
Anatole A. Klyosov | 78 | 2000 | Co-founder & Member of the Scientific Board |
Richard E. Uihlein | 80 | 2017 | Independent Chairman |
Gilbert F. Amelio | 82 | 2009 | Independent Director |
Harold H. Shlevin | 75 | 2012 | Director |
Naga Chalasani | - | - | Member of Clinical Advisory Board |
Kary Eldred | 51 | 2018 | Independent Director |
Joel Lewis | 55 | 2017 | President, CEO & Director |
Mohammad Siddiqui | - | - | Member of Clinical Advisory Board |
Thomas D. Schiano | - | - | Member of Clinical Advisory Board |
Ram Subramanian | - | - | Member of Clinical Advisory Board |
Marc Rubin | 70 | 2011 | Independent Director |
Brent Tetri | - | - | Member of Clinical Advisory Board |
Stephen A. Harrison | - | - | Member of Clinical Advisory Board |
Arun J. Sanyal | - | - | Member of Clinical Advisory Board |
Benjamin S. Carson | 74 | 2023 | Independent Director |
Richard A. Zordani | 52 | 2020 | Independent Director |
Elissa J. Schwartz | 54 | 2020 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review